Verrica Pharmaceuticals Inc. (VRCA) Operating cash flow 2017–2025
Verrica Pharmaceuticals Inc. (VRCA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$17.6MFY2025 · since FY2017: -$4.6M → -$17.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.6M | +71.1% |
| FY2024 | -$60.9M | -57.9% |
| FY2023 | -$38.6M | -106.8% |
| FY2022 | -$18.6M | +32.4% |
| FY2021 | -$27.6M | +8.7% |
| FY2020 | -$30.2M | -10.2% |
| FY2019 | -$27.4M | -53.3% |
| FY2018 | -$17.9M | -290.0% |
| FY2017 | -$4.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice